Blog / Buyer reference

Prices, stock and straight answers.

72 practical briefs for peptide buyers in the Philippines. Real peso prices, real delivery timelines, written by the team that packs the vials.

Comparisons

10 posts

Retatrutide vs tirzepatide: price and research profile

The triple agonist against the dual agonist: trial results, peso pricing and which question each answers.

Read

Retatrutide vs semaglutide: the cost-per-result math

The newest incretin versus the original blockbuster, compared on published data and Philippine pricing.

Read

Tirzepatide vs semaglutide in the Philippines

SURMOUNT-5 settled the head-to-head. What that means for research buyers choosing between the two locally.

Read

BPC-157 vs TB-500: different mechanisms, one stack

Angiogenic signaling versus actin regulation: what each is studied for and why protocols often run both.

Read

NAD+ vs NMN: precursor or the molecule itself

Supplement counters sell NMN. Research protocols use NAD+ directly. The difference, priced in pesos.

Read

GHK-Cu injectable vs topical: two research routes

Systemic protocols versus dermal formulation work, and how one 50mg vial serves both.

Read

CJC-1295/Ipamorelin vs sermorelin

The modern blend against the older GHRH analog: half-life, pulse quality and availability in the Philippines.

Read

MOTS-c vs NAD+ in longevity research

Mitochondrial signaling versus the redox substrate: two layers of the same research question.

Read

RUO vials vs pharmacy GLP-1 pens in the Philippines

Ozempic pens at five figures versus RUO vials at four: what actually differs and what does not.

Read

Vial sizes and value: reading peso-per-milligram

Why a 20mg vial can beat a cheaper 10mg listing, with the per-milligram table for the whole catalogue.

Read